FindTrial
Sign In

Pneumococcal conjugate vaccine GSK1024850A

BIOLOGICAL8 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BInfections, StreptococcalNeisseria MeningitidisPoliomyelitisStreptococcus Pneumoniae

Phase 3

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
CompletedNCT00344318
GlaxoSmithKlineInfections, Streptococcal
Start: 2006-08-07End: 2007-10-17Updated: 2018-12-07
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants
CompletedNCT00390910
GlaxoSmithKlineInfections, Streptococcal
Start: 2006-10-01End: 2008-05-02Updated: 2018-12-17
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
CompletedNCT00463437
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Hepatitis B +3
Start: 2007-04-25End: 2008-06-14Updated: 2020-01-02
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine
CompletedNCT00466947
GlaxoSmithKlineInfections, Streptococcal
Start: 2007-06-28End: 2011-07-28Updated: 2019-07-16
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A
CompletedNCT00792909
GlaxoSmithKlineInfections, Streptococcal
Start: 2008-12-02End: 2009-07-02Updated: 2017-12-14
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age
CompletedNCT00814710
GlaxoSmithKlineInfections, Streptococcal, Streptococcus Pneumoniae
Start: 2009-03-07End: 2009-11-13Updated: 2020-01-03
Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease
CompletedNCT00861380
GlaxoSmithKlineInfections, Streptococcal, Streptococcus Pneumoniae
Start: 2009-05-04End: 2013-10-05Updated: 2020-12-17
Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines
CompletedNCT00891176
GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis
Start: 2009-05-14End: 2012-11-21Updated: 2018-02-15

Related Papers

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial
PLoS ONE2022-01-05
Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants – Results from a randomized, double-blind vaccine trial
Vaccine2019-05-2010 citations
Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial
Vaccine2018-08-2316 citations
Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial
Vaccine2018-03-0137 citations
Efficacy of 10-valent pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – A randomized controlled trial
Human Vaccines & Immunotherapeutics2017-02-2629 citations
Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies
Human Vaccines & Immunotherapeutics2016-10-137 citations
Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
Clinical and Vaccine Immunology2016-05-05
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
2016-04-2865 citations
Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
2014-08-0735 citations
Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Children in India
Clinical and Vaccine Immunology2014-07-109 citations
Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
PLoS Medicine2014-06-03221 citations
Safety and immunogenicity of 10-valent pneumococcal nontypeable<i>Haemophilus influenzae</i>protein D conjugate vaccine (PHiD-CV) in Nigerian children
Human Vaccines & Immunotherapeutics2013-12-049 citations
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
2013-11-2666 citations
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
2012-11-16168 citations
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
2009-04-0167 citations